Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Boschetto, I. Campo, M. Stendardo, E. Casimirri, C. Tinelli, C. Ceconi, A. Fucili, A. Potena, L. Ballerin, L. M. Fabbri, M. Luisetti (Pavia, Modena, Italy). Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease. Eur Respir J 2012; 40: Suppl. 56, 213

Member's Comments

No comment yet.

Related content which might interest you: Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Advanced glycation endproducts are increased in lung tissue from patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Reduced soluble receptor for advanced glycation end-products in COPD Source: Eur Respir J 2011; 37: 516-522 Year: 2011 Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005 Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Reduced myofibrillar protein breakdown in stable patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Association between endothelial dysfunction and nutrient consumption in patients with chronic obstructive pulmonary disease and heart failure. Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Determinants of peripheral blood neutrophils in advanced chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007